A macromolecular delivery vehicle for protein-based vaccines:: Acid-degradable protein-loaded microgels

被引:332
作者
Murthy, N
Xu, MC
Schuck, S
Kunisawa, J
Shastri, N
Fréchet, JMJ [1 ]
机构
[1] Univ Calif Berkeley, Ctr New Direct Organ Synth, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[3] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA
[4] Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA
关键词
polymer crosslinker; encapsulation; vaccination; cytotoxicT; lymphocyte;
D O I
10.1073/pnas.0930644100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The development of protein-based vaccines remains a major challenge in the fields of immunology and drug delivery. Although numerous protein antigens have been identified that can generate immunity to infectious pathogens, the development of vaccines based on protein antigens has had limited success because of delivery issues. In this article, an acid-sensitive microgel material is synthesized for the development of protein-based vaccines. The chemical design of these microgels is such that they degrade under the mildly acidic conditions found in the phagosomes of antigen-presenting cells (APCs). The rapid cleavage of the microgels leads to phagosomal disruption through a colloid osmotic mechanism, releasing protein antigens into the APC cytoplasm for class I antigen presentation. Ovalbumin was encapsulated in microgel particles, 200-500 nm in diameter, prepared by inverse emulsion polymerization with a synthesized acid-degradable crosslinker. Ovalbumin is released from the acid-degradable microgels in a pH-dependent manner; for example, microgels containing ovalbumin release 80% of their encapsulated proteins after 5 h at pH 5.0, but release only 10% at pH 7.4. APCs that phagocytosed the acid-degradable microgels containing ovalbumin were capable of activating ovalbumin-specific cytoxic T lymphocytes. The acid-degradable microgels developed in this article should therefore find applications as delivery vehicles for vaccines targeted against viruses and tumors, where the activation of cytoxic T lymphocytes is required for the development of immunity.
引用
收藏
页码:4995 / 5000
页数:6
相关论文
共 25 条
  • [1] Barton J, 2000, POLYM INT, V49, P358, DOI 10.1002/(SICI)1097-0126(200004)49:4<358::AID-PI376>3.0.CO
  • [2] 2-1
  • [3] Strategies for designing and optimizing new generation vaccines
    Berzofsky, JA
    Ahlers, JD
    Belyakov, IM
    [J]. NATURE REVIEWS IMMUNOLOGY, 2001, 1 (03) : 209 - 219
  • [4] Live attenuated HIV vaccines: Predicting the tradeoff between efficacy and safety
    Blower, SM
    Koelle, K
    Kirschner, DE
    Mills, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) : 3618 - 3623
  • [5] Caetano R S., 1995, J. Exp. Med, V182, P841
  • [6] ENZYME IMMOBILIZATION IN NANOPARTICLES PRODUCED BY INVERSE MICROEMULSION POLYMERIZATION
    DAUBRESSE, C
    GRANDFILS, C
    JEROME, R
    TEYSSIE, P
    [J]. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1994, 168 (01) : 222 - 229
  • [7] INCORPORATION OF MACROMOLECULES IN MICROPARTICLES - PREPARATION AND CHARACTERISTICS
    EKMAN, B
    LOFTER, C
    SJOHOLM, I
    [J]. BIOCHEMISTRY, 1976, 15 (23) : 5115 - 5120
  • [8] Controlled release of a model protein from enzymatically degrading dextran microspheres
    Franssen, O
    Stenekes, RJH
    Hennink, WE
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 59 (02) : 219 - 228
  • [9] Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages
    Gagnon, E
    Duclos, S
    Rondeau, C
    Chevet, E
    Cameron, PH
    Steele-Mortimer, O
    Paiement, J
    Bergeron, JJM
    Desjardins, M
    [J]. CELL, 2002, 110 (01) : 119 - 131
  • [10] MHC class I-restricted CTL responses to exogenous antigens
    Jondal, M
    Schirmbeck, R
    Reimann, J
    [J]. IMMUNITY, 1996, 5 (04) : 295 - 302